Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Stem cells are crucial for skin repair and new treatments for chronic wounds.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

Wnt10b helps blood stem cells grow after injury.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Using a combination of AMD3100 and FK506 can speed up and improve wound healing in diabetic rats.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Genetically-altered adult stem cells can help in wound healing and are becoming crucial in regenerative medicine and drug design.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.